Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001204898 | SCV001376127 | likely benign | Primary ciliary dyskinesia | 2024-11-27 | criteria provided, single submitter | clinical testing | |
Gene |
RCV002298902 | SCV002588006 | uncertain significance | not provided | 2022-04-27 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV001204898 | SCV002706910 | likely benign | Primary ciliary dyskinesia | 2021-09-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001204898 | SCV002078453 | uncertain significance | Primary ciliary dyskinesia | 2020-02-21 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003918778 | SCV004730472 | uncertain significance | DNAH5-related disorder | 2023-10-18 | no assertion criteria provided | clinical testing | The DNAH5 c.10435G>A variant is predicted to result in the amino acid substitution p.Ala3479Thr. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.10% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/5-13754432-C-T). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |